AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal Post author:Sam Post published:December 28, 2017 Post category:BioPharma ANI Phamaceuticals funded the acquisitions through a combination of cash and debt. Source: BioSpace You Might Also Like Troubling Times for Shire as Execs Jump Ship and Employee Satisfaction is at an All Time Low August 30, 2017 Stada Names Novartis Exec as New CEO, It's Fifth Leader Since 2016 January 31, 2018 PTC Therapeutics CEO to Fight for DMD Therapy, Pushes Forward with SMA Treatment January 10, 2018
Troubling Times for Shire as Execs Jump Ship and Employee Satisfaction is at an All Time Low August 30, 2017
